One patent currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2042. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2042
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2025 to 2042.
US 12,364,759
Polymer-Particle Light-Cleavable Carrier Systems for Photodynamic Therapy
Jun 12, 2042
20292033203720412042
Every computed term in this portfolio is shown above.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
- 1 term has ended since Aug 23, 2026
- Aug 26 US 8,815,931 Oral Formulations for Tetrapyrrole Derivatives · lapsed on the fee record
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Polymer-Particle Light-Cleavable Carrier Systems for Photodynamic Therapy | 1 in force | to Jun 2042 |
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,364,759 | Polymer-Particle Light-Cleavable Carrier Systems for Photodynamic Therapy In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 1 patent ended. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.